Clinical [qlco]
Efficacy [qlco]
Safety [hcpp]
cilostazol [orch, phsu]
Critical [qlco]
Review [inpr]
Literature [inpr]
cilostazol [orch, phsu]
Unique [qlco]
Antiplatelet agent [phsu]
Available [ftcn]
Over [spco]
Two [qnco]
Decade [qnco]
Phosphodiesterase III Inhibitor [moft]
arrested [dsyn]
Platelet aggregation [celf]
possess [mobd]
properties [qlco]
Study [mnob]
Variety [cnce]
Disease [dsyn]
State [geoa]
Including [ftcn]
peripheral arterial disease [dsyn]
Cerebrovascular disease [patf]
coronary artery disease [dsyn]
Percutaneous Coronary Intervention [topp]
Overall [inpr]
cilostazol [orch, phsu]
APPEAR [qlco]
To [qlco]
promise [idcn]
Agent [chvf]
Management [ocac]
Disease [dsyn]
State [geoa]
Bleeding [patf]
Profile [lbpr]
placebo [topp]
Combined [qlco]
Antiplatelet Agents [phsu]
cilostazol [orch, phsu]
Not [ftcn]
APPEAR [qlco]
To [qlco]
Increase [ftcn]
Rate [acty]
Bleeding [patf]
Possible [qlco]
Benefit [qnco]
cilostazol [orch, phsu]
Limited [ftcn]
TOLERABILITY [resa]
Patients [podg]
Often [tmco]
Report [inpr]
Drug [phsu]
Discontinuation [hlca]
Headache [sosy]
Diarrhea [sosy]
Dizziness [sosy]
Increased heart rate [fndg]
Date [tmco]
Study [mnob]
Asian [popg]
Population [qnco]
Make [ftcn]
Difficult [qlco]
Result [ftcn]
More [ftcn]
Diverse [qlco]
Population [qnco]
This [euka]
Paper [mnob]
Evolving [ftcn]
Role [socb]
cilostazol [orch, phsu]
treatment [ftcn]
Vascular Diseases [dsyn]
